86315-08-4

Usage

Uses

Used in Pharmaceutical Industry:
3-Chloro-2-Methyl-6-nitrobenzoic acid is used as an intermediate in the synthesis of various pharmaceuticals for its ability to be chemically modified to produce active drug compounds. Its presence in the molecular structure can influence the pharmacological properties of the final product, such as solubility, stability, and bioavailability.
Used in Agrochemical Industry:
In the agrochemical sector, 3-Chloro-2-Methyl-6-nitrobenzoic acid is used as a precursor in the development of pesticides and other crop protection agents. Its chemical structure can be tailored to target specific pests or diseases, enhancing the effectiveness and selectivity of the resulting agrochemicals.
Used in Research Laboratories:
3-Chloro-2-Methyl-6-nitrobenzoic acid is employed as a research compound in academic and industrial laboratories. It serves as a building block for the synthesis of novel organic compounds and materials, contributing to the advancement of chemical knowledge and the discovery of new applications in various fields.

Upstream product

• 51123-60-5 3-CHLORO-2-METHYL-6-NITROBENZONITRILE 
• 7499-08-3 3-chloro-2-methylbenzoic acid 

Relevant academic research and scientific papers

Quinoline derivatives and preparation method and application thereof

The invention belongs to the technical field of insecticides and acaricides, and particularly relates to quinoline derivatives and a preparation method and application thereof. The invention particularly provides a compound shown as a formula (I) or salt thereof. The compound shown as the formula (I) has good activity on various pests and mites in agriculture or other fields. Moreover, the compounds can obtain a very good prevention and treatment effect at a very low dosage, so that the compounds can be used for preparing insecticides and/or acaricides. In addition, the preparation steps of the compound are simple, and the product yield is high, so that the compound has a good application prospect.

INHIBITORS OF CXCR2

Compounds are provided as inhibitors of CXCR2, having the structure:

MODULATORS OF CHEMOKINE RECEPTORS

Compounds are provided as chemokine inhibitors having the structure: Formula (A).

INHIBITORS OF CXCR2

Compounds are provided as inhibitors of CXCR2, having the structure (I).

Imidazoquinazoline derivatives which inhibit the aggregation of blood platelets, inhibit gastric secretion or have activity on the circulatory system

Imidazoquinazolines of the formula STR1 wherein one of R1 or R2 is hydrogen, chlorine, bromine, C1-4 -n-alkyl or C1-4 -n-alkoxy and the other is --N(R,R"), wherein R and R" are C1-4 -n-alkyl or R and